A New Approach to Treating Brain Cancer: HDT Bio Launches Canadian Clinical Program at McGill University Jul 14, 2026 | Press Releases, Uncategorized
Translational development of a tumor junction opening technology — Scientific Reports May 11, 2022 | UncategorizedClick here to view...
Suppression of hepatitis B virus through therapeutic activation of RIG-I and IRF3 signaling in hepatocytes — PubMed (nih.gov) Jan 4, 2021 | UncategorizedClick here to view...
Spatiotemporal dynamics of innate immune signaling via RIG-I-like receptors — PubMed (nih.gov) Jul 7, 2020 | UncategorizedClick here to view...
Structure-based Design of JOC-x, a Conjugatable Tumor Tight Junction Opener to Enhance Cancer Therapy Apr 16, 2019 | UncategorizedClick here to view...
Beyond sensing: Retinoic acid inducible gene-I (RIG-I) continues to expand its antiviral effector functions — PubMed (nih.gov) Jun 6, 2017 | UncategorizedClick here to view...
